相似文献
1
The effect of atrial natriuretic peptide on human isolated resistance arteries.
Br J Pharmacol. 1989 Aug;97(4):1027-30. doi: 10.1111/j.1476-5381.1989.tb12558.x.
2
Action of atrial natriuretic peptide (ANP) on dog cerebral arteries: evidence that neurogenic relaxation is not mediated by release of ANP.
Br J Pharmacol. 1989 Aug;97(4):1258-64. doi: 10.1111/j.1476-5381.1989.tb12587.x.
3
Factors mediating a regional difference in vasorelaxing effects of human natriuretic polypeptide in dogs.
Arch Int Pharmacodyn Ther. 1989 Mar-Apr;298:198-209.
4
Effects of atrial natriuretic peptide and toad heart extract on isolated toad Bufo arenarum aortic rings.
Gen Comp Endocrinol. 1992 Dec;88(3):424-33. doi: 10.1016/0016-6480(92)90237-e.
5
Size and site-dependent heterogeneity of human vascular responses in vitro.
J Hypertens Suppl. 1988 Dec;6(4):S173-5. doi: 10.1097/00004872-198812040-00051.
6
Changes in ANP responsiveness of normal and hypertensive porcine intrapulmonary arteries during maturation.
Pediatr Res. 1999 Oct;46(4):411-8. doi: 10.1203/00006450-199910000-00009.
7
Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide.
J Pharmacol Exp Ther. 1990 Mar;252(3):1234-9.
8
Vasodilator responses to alpha-human-atrial natriuretic peptide in isolated omental and pulmonary arteries from rabbit and man.
Acta Physiol Scand. 1988 Nov;134(3):391-7. doi: 10.1111/j.1748-1716.1988.tb08506.x.
9
Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide.
Can J Physiol Pharmacol. 1989 Apr;67(4):326-30. doi: 10.1139/y89-053.
10
Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
J Clin Invest. 1993 Oct;92(4):2048-52. doi: 10.1172/JCI116800.
引用本文的文献
1
Cardiac and Vascular Remodeling After 6 Months of Therapy With Sacubitril/Valsartan: Mechanistic Insights From Advanced Echocardiographic Analysis.
Front Cardiovasc Med. 2022 May 18;9:883769. doi: 10.3389/fcvm.2022.883769. eCollection 2022.
本文引用的文献
1
Peripheral vascular resistance.
Am Heart J. 1960 Jul;60:1-5. doi: 10.1016/0002-8703(60)90054-5.
2
Functional and morphological properties of human omental resistance vessels.
Blood Vessels. 1981;18(6):233-44. doi: 10.1159/000158357.
3
Do resistance vessel abnormalities contribute to the elevated blood pressure of spontaneously-hypertensive rats? A review of some of the evidence.
Blood Vessels. 1983;20(1):1-22. doi: 10.1159/000158455.
4
Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP).
Biochem Biophys Res Commun. 1984 Jan 13;118(1):131-9. doi: 10.1016/0006-291x(84)91077-5.
5
Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7661-4. doi: 10.1073/pnas.81.23.7661.
6
Neurohypophyseal hormones and analogues: rat pressor potency versus contractile potency on rat arterioles and arteries.
Proc Soc Exp Biol Med. 1974 Sep;146(4):1054-60. doi: 10.3181/00379727-146-38245.
7
Lack of effect of atriopeptin II on rabbit glomerular arterioles in vitro.
Am J Physiol. 1987 Feb;252(2 Pt 2):F317-21. doi: 10.1152/ajprenal.1987.252.2.F317.
8
Effects of atriopeptins on relaxation and cyclic GMP levels in human coronary artery in vitro.
Eur J Pharmacol. 1986 May 13;124(1-2):193-6. doi: 10.1016/0014-2999(86)90144-5.
9
Atriopeptins as cardiac hormones.
Hypertension. 1985 Jul-Aug;7(4):469-82. doi: 10.1161/01.hyp.7.4.469.
10
Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro.
Clin Sci (Lond). 1988 Feb;74(2):207-11. doi: 10.1042/cs0740207.
Zotero 插件